GeneTex

  • Country / Location Selection

United States (US)

SPTLC1 blocking peptide

Cat No. GTX32011-PEP

Application

 Neutralizing/Inhibition
Package
50 μg ($139)
See all SPTLC1 products
PRODUCT

Summary

SPTLC1 peptide is used for blocking the activity of SPTLC1 antibody (catalog number GTX32011).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl), 0.1% BSA, 0.02% sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

Serine Palmitoyltransferase Long Chain Base Subunit 1 , Hsan1 , Hsn1 , Lbc1 , Lcb1 , Spt1 , Spti , Sptlc1

Background

Serine palmitoyltransferase, which consists of two different subunits, is the key enzyme in sphingolipid biosynthesis. It converts L-serine and palmitoyl-CoA to 3-oxosphinganine with pyridoxal 5'-phosphate as a cofactor. The product of this gene is the long chain base subunit 1 of serine palmitoyltransferase. Mutations in this gene were identified in patients with hereditary sensory neuropathy type 1. Alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for SPTLC1 blocking peptide (GTX32011-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for SPTLC1 blocking peptide (GTX32011-PEP). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139